These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 8445603

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O, Richard-Davis G, Morris T, Armstrong J.
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas.
    Vercellini P, Bocciolone L, Colombo A, Vendola N, Meschia M, Bolis G.
    Acta Obstet Gynecol Scand; 1993 Jul; 72(5):369-73. PubMed ID: 8392268
    [Abstract] [Full Text] [Related]

  • 6. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG, Vercellini P, Meschìa M, Oldani S, Bramante T.
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE, Anania C, Malinak R.
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The use of ferritin in 40 patients with iron deficiency of various degrees caused by gynecologic disorders].
    Bottino G, Menna C, Giarratana L, Marini C, Viberti G.
    Minerva Ginecol; 1990 Jun; 42(6):275-6. PubMed ID: 2381559
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
    Giancaspro V, Nuzziello M, Pallotta G, Sacchetti A, Petrarulo F.
    J Nephrol; 2000 Jun; 13(6):444-9. PubMed ID: 11132761
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of dysfunctional metrorrhagia with GnRH analogs].
    Zanella B, Bertelli E, Guerra S, Lenzi B, Mari MC.
    Minerva Ginecol; 1992 Oct; 44(10):521-3. PubMed ID: 1461555
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects on the male endocrine system of long-term treatment with gonadotropin-releasing hormone agonists and estrogens in male-to-female transsexuals.
    Mueller A, Binder H, Cupisti S, Hoffmann I, Beckmann MW, Dittrich R.
    Horm Metab Res; 2006 Mar; 38(3):183-7. PubMed ID: 16673210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.